about
Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin CifMultidrug resistance related molecules in human and murine lungMultidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsATP-binding cassette (ABC) transporters in normal and pathological lungThe human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1.Renal drug transporters and their significance in drug-drug interactionsHomologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegansThe blood-testis barrier and its implications for male contraceptionAllyl isothiocyanate increases MRP1 function and expression in a human bronchial epithelial cell lineMultidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical applicationBreast cancer resistance protein regulates apical ectoplasmic specialization dynamics stage specifically in the rat testisNew highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer.Metabolism, toxicity and anticancer activities of arsenic compounds.ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNSXenobiotic, bile acid, and cholesterol transporters: function and regulation.Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin.Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymesChoroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.Functional evidence of multidrug resistance transporters (MDR) in rodent olfactory epitheliumLapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.Molecular and pharmacological strategies to overcome multidrug resistance.ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment: possible implications for cancer chemotherapyIn vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.Drug transporters, the blood-testis barrier, and spermatogenesisGenetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1-MRP1) in the Polish populationNitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteinsThe G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenalEpitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.Expression and significance of angiopoietin-2 in gastric cancer.Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomasMultidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage.The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerLoss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac FibroblastsBreast cancer resistance protein (Bcrp) and the testis--an unexpected turn of events.Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells.
P2860
Q24647608-9B4C1BBD-4ABE-42AF-9399-23835188DCB4Q24673081-CA801CE4-C419-46D8-9824-C37D11C0B692Q24681283-3FCD5DA6-E567-4D0F-920B-F783CC0D787AQ24811895-7883B79E-0573-47C1-9A4C-294506CBD464Q27935067-95CA180E-CDD2-488A-9CC1-32251B0FD3A1Q28071292-86C1D412-67F9-42D3-8637-21B6BEFC3DE0Q28379341-B99E410B-43D5-450B-9579-8D7454C3901EQ28395237-9BCF82C2-EA95-47BB-B10B-551F76CD9C5AQ28396851-4F10B474-7ADD-43DE-9399-BB34C77287CEQ28468693-D67ED603-30DC-418F-8A46-99A1A4630DA6Q28579813-672D85A1-BD62-4BBE-99E1-C84C4615F74FQ31440627-53A7CE26-7EF8-4008-963F-7791E81B0749Q33618916-B1BEA6A4-DF54-4927-A494-2781ECCC6DC3Q33651875-A7EBE0C8-69FC-411C-BE50-C45EE4371F6CQ33714593-A77083AD-D9EB-47FF-9F9E-98DD6C913554Q33764085-2DC26B0A-DBF0-448C-8F73-B976C47A0641Q33823515-9CA7318A-C2E8-4C78-8FBB-0C1E271E6894Q33856562-F2D14368-489C-4F05-91DF-F6799D6CA329Q33890135-835D7D7F-E187-41ED-8F63-0D7D8800FC95Q34260070-C1EC1881-2890-4F66-8E56-4D1211B80BFEQ34416223-358FF01B-869B-44BC-90A5-F12FABC6FD70Q34734178-8975AC82-D853-49F8-ADF1-ACA596E55F3EQ34808344-920899FB-9D1A-43B7-AED8-F4C006EC8313Q34914312-CB77609B-A6FE-4A11-92FB-9E1E58A1839AQ35240133-D69193F1-8CF3-46B2-881D-A5E4EC32780CQ35784144-70E7F712-97AF-4A47-95D9-6C280271CF0DQ35802014-28B9598D-C64A-45D0-ABC7-635F3F202740Q35840905-7CA54013-0A3F-4115-B0A5-B97E0393ADCAQ36115145-FAC4A68F-251D-486B-B18D-07848BC64CDDQ36186168-6F6E9F0E-94A1-4221-8EE3-F86966EFDFB4Q36213796-2062B0CA-76C5-4810-BBD5-7653B8929B2AQ36213890-DF136854-A194-4316-82E0-F89A25592EAFQ36254830-531A1D00-34A5-4087-81FC-F40F22C73073Q36276948-F2A5882D-56C7-4A75-A8C6-17247242FFEAQ36291762-10158DC0-552C-41B9-A8D5-1AD55B5C640AQ36404168-ACAE93B5-3D79-4C3E-94BD-D4DDC3D86984Q36430961-B2B3B795-A60B-461E-938A-F6FDAB2E954BQ37023604-A1F2A27F-8ED7-4750-B69D-E8336265B211Q37084405-506179F4-E9E7-40A9-8D9F-8261A14C3849Q37095750-435D88E7-036B-45C4-8243-57A066098848
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Major vault protein LRP-related multidrug resistance
@ast
Major vault protein LRP-related multidrug resistance
@en
type
label
Major vault protein LRP-related multidrug resistance
@ast
Major vault protein LRP-related multidrug resistance
@en
prefLabel
Major vault protein LRP-related multidrug resistance
@ast
Major vault protein LRP-related multidrug resistance
@en
P2093
P2860
P3181
P1476
Major vault protein LRP-related multidrug resistance
@en
P2093
A.B. Schroeijers
G.L. Scheffer
M.A. Izquierdo
M.J. Flens
P. van der Valk
R.J. Scheper
P2860
P304
P3181
P356
10.1016/0959-8049(96)00053-6
P577
1996-06-01T00:00:00Z